图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:LANCET ONCOLOGY

ISSN:1470-2045
出版频率:Monthly
出版社:ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169
  出版社网址:http://www.elsevier.com/wps/find/homepage.cws_home
期刊网址:http://www.elsevier.com/wps/find/journaldescription.cws_home/621215/description#description
影响因子:41.316
主题范畴:ONCOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

The aim of The Lancet Oncology is to publish interesting and informative reviews on any topic connected with oncology. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. Because the readership covers a wide range of specialties, it is vital that articles should be written clearly, and should not assume a level of knowledge above that of, say, a reasonably well-read, recently-qualified, doctor in training. The importance of a clear, accessible writing style cannot be stressed too highly. One way to find out if your article is understandable to those reading outside their immediate field of interest is to show the manuscript to colleagues in other specialties. If they find it difficult to follow, so will a good proportion of the readership. Wherever possible, diagrams, figures, and good quality photographs (colour or black and white) should be used to supplement and enhance the text. Further details on the different sections of The Lancet Oncology, and how to submit to the journal, are given below. If you require further clarification, the journal's editorial staff will be pleased to help.


Instructions to Authors
Submission categories

Newsdesk - Articles in this section are generally written by professional journalists but if you know of an event that might be of wider interest to the oncology community then please contact the Editor with your ideas.

Reportage - These 1500-1750 word essays (with 2-3 pictures) are written in a journalistic style and provide a thorough overview of cancer services in a particular country or region. Our aim is to draw attention to less developed countries, but reports from developed countries that receive little coverage are also welcome. As with the Newsdesk, these articles are usually written by commissioned professional journalists but if you have an idea for inclusion please contact the Editor.

Reflection and reaction - This section has a dual function. First, it contains commentaries on either research papers published within the past 3 months or topical issues in oncology. Most commentaries are commissioned, but unsolicited ones (no more than 800 words, 10 references and one figure) are also welcome. Unsolicited commentaries will be peer reviewed. Second, this section is the home of correspondence letters, written in response to previous content published in The Lancet Oncology or on any topic of general interest or concern.

Reviews - These may be commissioned by in-house editors or submitted unsolicited, although in the latter case it would be wise to send the Editor a one-page outline first, to ensure that a review on the same subject has not already been commissioned. Articles will be peer reviewed before an editorial decision is made. Reviews should either be definitive overviews of a major topic connected with oncology or updates of knowledge in a somewhat narrower field of current interest. The word count should be between 3000 and 4500 words, depending on the breadth of the topic, and should include a maximum of 75 references. References selected for publication in the journal should be chosen for their importance, ease of access, and for the 'further reading' opportunities they provide. Following the references, authors should consider supplying a short list of useful websites where readers can find further information on the subject. The Lancet Oncology welcomes systematic reviews, prepared according to the Cochrane Collaboration guidelines. However, when conducting any literature review, it is important that there is complete transparency concerning the choice of material included. All review articles submitted for publication in The Lancet Oncology must therefore contain a brief section entitled Search strategy and selection criteria. This should state clearly the sources (databases, journals, or book reference lists, etc) of the material covered and the criteria used to include or exclude studies; for example, English language only or studies conducted after a specific date.

Example:

Search strategy and selection criteria
Data for this review were identified by searches of MEDLINE, Current Contents, PubMed, and references from relevant articles using, the search terms 'sentinel node', 'breast cancer', and 'axilla'. Abstracts and reports from meetings were included only when they related directly to previously published work. Only papers published in English between 1980 and 2000 were included.

Historical reviews - These should follow the same rules and guidelines as for Reviews but should cover the chronological developments in an important or interesting area of oncology.

Personal views - These should be around 2000-4500 words in length, with a maximum of 75 references. These opinion pieces are thought-provoking essays on an oncological subject and may reflect an individual perception, involvement, or contribution to oncology, but must be prepared in a similar way to a Review article. See submission requirements outlined for Reviews for further details. Unsolicited contributions are welcome, although as with Reviews it is best to contact the Editor before submission to ensure that the proposed topic is within the remit of the journal.

Essays - Essays can be narrower in scope than Personal views and may be used to discuss a personal perspective or philosophy about an oncology-related subject. Word length is limited to 2000 words, with a maximum of 50 references. All Essays should include one or two appropriate illustrations.

Case reports - Case reports should describe single interesting or unusual cases, including those describing rare cancers, in which the initial appearance, the possible diagnoses, or the treatment regimens used, might be of help or interest to other oncologists. The text should be not more than 1000 words, plus five references. The inclusion of up to two clinical photographs is strongly encouraged. At least one of the authors should have been clinically responsible for the patient. Consent for publication in print and electronically must be obtained before submission, from the patient or, if this is not possible, from their next of kin. A consent form is available at http://image.thelancet.com/extras/tloconsentform.pdf. All Case reports are peer-reviewed prior to publication.

Clinical pictures - These should feature interesting or unusual clinical photographs, accompanied by a brief text (maximum 200 words) describing the picture, explaining the context, and either describing the outcome or drawing attention to the features of interest, as appropriate. There should be no references and signed consent from the patient (or relatives, where the patient has died) must be supplied before publication can proceed. See information on Case reports for consent form details.

Advances in research - These are similar to Clinical pictures but should feature novel groundbreaking images from preclinical studies in an oncological environment. Photographs must be accompanied with a brief paragraph of text (maximum 200 words) describing the picture, explaining the context, or drawing attention to the key features of interest, as appropriate. There should be no references.

Forums - These are a platform for discussing controversies in oncology. Each Forum contains three or more 800-word opinion pieces written by oncologists, researchers, nurses, patients, and others with an interest in the topic under discussion. While in-house editors commission these, suggestions for topics from the journal's readers are very welcome.

De libris/Where on the web - Readers with an interest in contributing book and/or web reviews should contact the Editor. In general, these submissions should be between 350 and 400 words.

Errata - Any substantial error in a published article will be corrected as soon as possible. Blame is not apportioned; the important thing is to set the record straight. If errors are spotted quickly, any reprints that have been ordered can usually be amended. Please contact the editorial team if you spot a major error in the journal.

General submission guidelines

Title page - A brief imaginative title, not exceeding 100 characters, a short running title, not exceeding 50 characters, and name(s), affiliation(s), current position(s), and full address(es) of the authors. The name and address of the corresponding author should be separately and clearly indicated, together with his/her telephone, fax, and email details.

Authors' contributions and signatures - The Lancet Oncology will not publish a Review, Historical review, Personal view, Case report, or Clinical picture unless it has the signatures of all authors along with all the initial submission.

Conflict of interest and source of funding - A conflict of interest exists when an author or the author's institution has financial or personal relationships with other people or organisations that inappropriately influence (bias) his or her actions. Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships, academic competition, or intellectual passion. A conflict can be actual or potential, and full disclosure to the Editor is the safest course. All submissions to The Lancet Oncology must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest (see Lancet 2001; 358: 854-56). The Editor may use such information as a basis for editorial decisions, and will publish such disclosures if they are believed to be important to readers in judging the manuscript. At the end of the text, under a subheading Conflict of interest, all authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications, and travel grants, all within 3 years of beginning the work submitted. If there are no conflicts of interest, authors should state that there are none. The Lancet Oncology may decide not to publish a Review on the basis of a declared financial interest of an author in a company (or its competitors) that makes a product discussed in the paper. However, we would much prefer such matters to be resolved earlier, at the commissioning stage.

Main text - Should begin with a summary of no more than 150 words, which briefly covers the content of the review. Use subheadings to break up the text in the main body of the article, and try to distribute references to the figures and tables evenly throughout the manuscript. Please include a short paragraph at the beginning, giving brief author(s) information (current position(s) and affiliations).

Permissions - A statement indicating permission to re-produce previously published material, to use illustrations or report information about identifiable people, or to name people for their contributions (personal communications etc) should be included.

References - These should be in the 'Vancouver' style, numbered in the order in which they first appear in the article. Titles of journals should be abbreviated according to the Index Medicus style (see http://www.nlm.nih.gov). Please ensure that reference numbering throughout the manuscript is not inserted using electronic referencing software, such as Endnote, because this can cause problems editing the article for publication. All references must be verified by the author(s) against original documents.

Manuscripts - Manuscripts can be submitted either electronically via email or as a paper copy, together with one set of original/high-resolution illustrations and two low-resolution copies. Text should be printed double-spaced on one side of A4/Letter-size paper, with wide margins. Please include a copy of the manuscript on a 3.5" computer disk in Word (up to version 97), WordPerfect, rtf (rich text), or text (ASCII) formats. The disk must be marked with the names of the authors, and the format and wordprocessor program used. Separate files should be used for the main text (plus references), the figure legends, and tables. The electronic version of the paper will be used, so this must match the paper version of the manuscript exactly. Note: please use protective packaging (cardboard, bubblewrap, etc) when sending original artwork, photographs, slides, and computer disks by mail. No responsibility will be taken for damaged material. Please keep copies of everything submitted.

Artwork - Inclusion of illustrations (slides, photographs, and good quality artwork) is strongly encouraged. The first figure for all Reviews, Historical reviews, and Personal views should be an eyecatching image that captures the general theme of the paper. It should have a width of 81 mm and a minimum resolution of 300 dpi. We can use artwork (photos and line art, eg graphs) created on Mac or PC computers. Artwork can be saved as either Generic EPS, TIFF, PICT, GIF, JPEG, Postscript, or Acrobat PDF files. Any drawn artwork should be sent as a postscript file. Line artwork (eg graphs, diagrams, etc) must be saved as vector files. Do not send graphs as bitmaps. All photos/photomicrograph files must be at least 300 dpi and 110 mm wide. Please submit your artwork on 3.5", Zip, or Jaz discs, CD-ROM, or email. If artwork is compressed use only Stuffit or SEA software. If required, further assistance can obtained from the editorial team.

Supplements

For information about The Lancet's editorial policy on The Lancet Oncology Supplements or to receive a quote please contact:

The Lancet Oncology:
Gemma Schaepman, Account Manager, CIP
Tel: +31 20 485 2930
Fax: +31 20 485 2940
Email:g.schaepman@elsevier.com

All submissions should be sent to: The Lancet Oncology, 32 Jamestown Road, London NW1 7BY, UK; or emailed to: hannah.brown@lancet.com.

Editorial Board
Contact information for THE LANCET Publishing Group:

Customer Services

North America

Toll Free Tel Phone: +1 (800) 462 6198
Direct Tel Number: +1 (407) 345 4033
Toll Free Fax: +1 (800) 327 9021
Direct Fax: +1 (407) 363 1354
Email:USLancetCS@elsevier.com

Europe and Rest of the World

T) +44 (0) 20 7611 4102
F) +44 (0) 20 7611 4479
E-mail:custserv@lancet.com

Customer Services Manager Krista Roberts

Sales and Production

London Office

THE LANCET Publishing Group
32 Jamestown Road
London, NW1 7BY
UK
T) +44 (0) 20 7424 4910
F) +44 (0) 20 7424 4911
E-mail:marketing@lancet.com
E-mail:clas.advertising@lancet.com
E-mail:reprints@lancet.com

Publisher Richard Horton
European Marketing Manager Donna Walton
Marketing Executive Marcus Parker
Marketing Administrator Stuart Rowe
International Classified Advertising Manager Avril Tait
Classified Sales Executive Khady Bah
Classified Sales Administrator Helen Fogarty
Advertising Executive Jenny Robertson
Ben Fisher
International Reprints Manager Sarah Downes
Reprints Administrators Caroline Caulton
Victoria Enever - Oncology
Elizabeth Drayton - Infectious Diseases
Greg Davies - Neurology
PR & Press Officer Richard Lane

New York Office

THE LANCET Publishing Group
360 Park Avenue South
New York, NY 10010-1710
USA
T) +1 (212) 633 3810
F) +1 (212) 633 3850


Reprints Domenick Marmorato
Classified Advertising John Baltazar
T) +1 (212) 633-3829
E-mail:j.baltazar@elsevier.com
Display Advertising (USA) Henry Blaney
T) +1 (212) 633-3648
E-mail:h.blaney@elsevier.com
Georgia Nikolaros
T) +1 (212) 633-3686
E-mail:g.nikolaros@elsevier.com

Philadelphia Office

THE LANCET Publishing Group
The Curtis Center
625 Walnut Street, Suite300
Philadelphia, PA 19106
USA
T) +1 (215) 238 7800
F) +1 (215) 238 6423


North American Marketing Manager Gretchen Hauselt
Assistant Marketing Manager Rachael Cedrone



Rights and Permissions

All requests to reproduce or make available any content from The Lancet journals - in whole - or in part, in any format, including translation - must be sent to:

Helen Wilson
Manager, Rights & Permissions
Elsevier Ltd.
PO Box 800
Oxford OX5 1DX UK
T) +44 (0) 1865 843830
F) +44 (0) 1865 853333
E-mail:permissions@elsevier.com

Editorial
THE LANCET

T) +44 (0) 20 7424 4910
F) +44 (0) 20 7424 4911
E-mail:editorial@lancet.com

Editor Richard Horton
Deputy Editor Astrid James
Executive Editors Sabine Kleinert
David McNamee
Pia Pini
Managing Editor Stephanie Clark
Molecular Medicine Editor Virginia Barbour
North American Editor Michael McCarthy (Seattle)
T) +1 206 706 7461
North American Senior Editor Faith McLellan (New York)
T) +1 212 633 3801
European Senior Editor Patricia Schlagenhauf (Zurich)
T) +41 1 3627604

THE LANCET Oncology

T) +44 (0) 20 7424 4950
F) +44 (0) 20 7424 4557
E-mail:david.collingridge@lancet.com
E-mail:hannah.brown@lancet.com

Editor David Collingridge
Senior Editor Hannah Brown
Assistant Editor Emma Wilkinson



THE LANCET Infectious Diseases

T) +44 (0) 20 7424 4959
F) +44 (0) 20 7424 4557
E-mail:john.mcconnell@lancet.com
E-mail:pamela.das@lancet.com

Editor John McConnell
Senior Editor Pam Das
Assistant Editor Rachael Paterson



THE LANCET Neurology

T) +44 (0) 20 7424 4956
F) +44 (0) 20 7424 4557
E-mail:james.butcher@lancet.com
E-mail:rebecca.love@lancet.com

Editor James Butcher
Senior Editor Rebecca Love
Assistant Editor Peter Hayward

 

Production

T) +44 (0) 20 7424 4976
F) +44 (0) 20 7424 4915

Production Manager Nicola Carter
Senior Electronic Production Engineer Colin Brown



Distribution and Circulation

Circulation Manager Margerita Turner

T) +44 (0) 20 7611 4126
F) +44 (0) 20 7611 4479


Distribution Controller Marian Herlihy

T) +44 (0) 20 7611 4241
F) +44 (0) 20 7611 4479


 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有